Question 1

What is the catalog number for EFHC2, NT (EFHC2, EF-hand domain-containing family member C2) (FITC) discontinued?

Accepted Answer

The catalog number for EFHC2, NT (EFHC2, EF-hand domain-containing family member C2) (FITC) discontinued is 034944-FITC.

Question 2

What sizes are available for EFHC2, NT (EFHC2, EF-hand domain-containing family member C2) (FITC) discontinued?

Accepted Answer

EFHC2, NT (EFHC2, EF-hand domain-containing family member C2) (FITC) discontinued is available in the following size(s): 200 µL.

Question 3

Is EFHC2, NT (EFHC2, EF-hand domain-containing family member C2) (FITC) discontinued in stock?

Accepted Answer

EFHC2, NT (EFHC2, EF-hand domain-containing family member C2) (FITC) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

Question 5

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 6

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

EFHC2, NT (EFHC2, EF-hand domain-containing family member C2) (FITC) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/1935), CF594 conjugate, 0.1mg/mL

Human IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker) (IGHM/3776R), CF640R conjugate, 0.1mg/mL

Smooth Muscle Myosin Heavy Chain (SM-MHC) (MYH11/2303R), CF647 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF740 conjugate, 0.1mg/mL

Erythropoietin (EPO) (Marker of Placentation Disorders) (EPO/3793R), CF405S conjugate, 0.1mg/mL

C1QB / Complement C1q B-Chain (C1QB/2961), CF594 conjugate, 0.1mg/mL